Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 1

Interventions

Cyclophosphamide 108 Rituximab 62 Etoposide 56 Methotrexate 52 Cytarabine 52 Peripheral Blood Stem Cell Transplantation 47 Vincristine 45 Filgrastim 43 fludarabine phosphate 41 Radiotherapy 37 Mycophenolic Acid 35 Doxorubicin 35 Tacrolimus 33 Busulfan 33 Whole-Body Irradiation 32 Prednisone 31 Methylprednisolone 27 Antilymphocyte Serum 27 Dexamethasone 26 Cyclosporine 26 Melphalan 24 merphos 20 blinatumomab 20 Leucovorin 20 Granulocyte Colony-Stimulating Factor 16 Carmustine 15 fludarabine 14 Ifosfamide 14 Calcium Dobesilate 14 CT-P10 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Burkitt Lymphoma × CVAD protocol × Clear all

NCT07564453 2026-05-04

FLOW

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡